Roche India launches Atezolizumab for treatment of TNBC
Approval from DCGI is based on data from phase III IMpassion130 study according to which Atezolizumab is proven to significantly…
Recover your password.
A password will be e-mailed to you.
- Advertisement -
Recover your password.
A password will be e-mailed to you.